Previous 10 | Next 10 |
Multiple waves of digitization have attempted to nudge the healthcare industry forward over the past decades. However, it still largely remains stuck in its old ways. Doximity (NYSE: DOCS), an evolving medical network, is approaching the modernization of healthcare in its own unique way...
Doximity (NYSE: DOCS) and Teladoc (NYSE: TDOC) are both leading companies with similar market caps in the healthcare space, but there are some important differences as well. In this Motley Fool Live segment from "The Pharma & Biotech Show," recorded on March 23 ,...
As a social media platform for medical professionals, Doximity (NYSE: DOCS) has been a hit, with a reported 80% of current doctors, nurses, and pharmacists currently using its network -- along with an impressive 100% of medical students. In this episode of "The Health & Fitness Show...
Doximity (NYSE: DOCS) , the medical professionals' social network and telemedicine company, is often likened to Microsoft 's LinkedIn. In this episode of "The Health & Fitness Show" on Motley Fool Live , recorded on March 25 , Fool.com contributor Rachel Warren discu...
Shares of telemedicine stock Doximity (NASDAQ: DOCS) dropped 15% last month due to market forces that weighed down on growth stocks . There wasn't any major news on the company, but the stock couldn't fight the tide that resulted in very similar charts for its telehealth peers. ...
Telemedicine -- medical care delivered via phone or internet video -- soared in 2020. That growth trend slowed in 2021 as many people returned to their doctors' offices. But the telemedicine trend isn't over. Big technology companies sure don't think so. Amazon (NASDAQ: AMZN) Care w...
Doximity (DOCS) is a high-quality company which we previously covered. At the time we came to the conclusion shares were too expensive. Since then shares have been almost cut in half, bringing us to ask ourselves if now is the time to start investing in the company. Now it has a m...
The market continues its volatile ride, which may leave many investors confused about how to play their positions. But it's really no different than a smooth, upward market if you have long-term goals in place. If you have money in the market, the best thing to do is read something other th...
The Rule of 40 is a quantitative way to measure the potential of SaaS companies' growth to create value, even if they're not profitable yet. I created a portfolio of SaaS companies that pass the Rule of 40. This article series tracks the performance of the portfolio over time. ...
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – March 16, 2022 – In the first year of the pandemic, telemedicine visits at key Medicaid providers increased by 2000%, according to a new survey by Health Net. Indeed, telehealth visi...
News, Short Squeeze, Breakout and More Instantly...
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Doximity, Inc. (NYSE: DOCS). On August 8, 2023, the Company disclosed disappointing guidance ...
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter ended June 30, 2024 after market close on August 8, 2024. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p...
2024-07-10 22:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...